BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7045784)

  • 21. Analysis of potential beneficial actions of prostaglandins in traumatic shock.
    Lefer AM; Araki H
    Prog Clin Biol Res; 1983; 111():199-210. PubMed ID: 6346328
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prostanoids in the physiology and pathology of the cardiovascular system].
    Markov KhM
    Kardiologiia; 1982 Mar; 22(3):13-24. PubMed ID: 6281511
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
    Nelson PK; Brookins J; Fisher JW
    J Pharmacol Exp Ther; 1983 Aug; 226(2):493-9. PubMed ID: 6410047
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostacyclin, a potent vasodepressor in primates.
    Fletcher JR; Corey EJ; Saba JL; Ramwell PW
    Prostaglandins; 1977 Nov; 14(5):1024. PubMed ID: 413161
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An antihypertensive effect of prostacyclin.
    Sutter DM; Weeks JR
    Adv Prostaglandin Thromboxane Res; 1980; 7():789-90. PubMed ID: 6989205
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulatory and pulmonary airway responses to different mixtures of prostaglandins E2 and F2 alpha in dogs.
    Nakano J; McCloy RB; Prancan AV
    Eur J Pharmacol; 1973 Oct; 24(1):61-6. PubMed ID: 4756169
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced hypotensive action of arachidonic acid in the spontaneously hypertensive rat.
    Lukacsko P; Messina EJ; Kaley G
    Hypertension; 1980; 2(5):657-63. PubMed ID: 6998871
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostacyclin infusion in hypertension: acute hemodynamic and hormonal effects.
    Chaignon M; Ruffie ML; Lucsko M; Cuche JL; Guedon J; O'Grady J
    N Engl J Med; 1982 Aug; 307(9):559. PubMed ID: 7048097
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals.
    Utsunomiya T; Krausz MM; Shepro D; Hechtman HB
    Am J Physiol; 1981 Nov; 241(5):H766-71. PubMed ID: 7030086
    [No Abstract]   [Full Text] [Related]  

  • 31. Thromboxanes and prostacyclin: positive and negative modulators of tumor growth.
    Honn KV; Meyer J
    Biochem Biophys Res Commun; 1981 Oct; 102(4):1122-9. PubMed ID: 6274330
    [No Abstract]   [Full Text] [Related]  

  • 32. Microvascular sensitivity to PGE2 and PGI2 in skeletal muscle of decerebrate rat.
    Faber JE; Harris PD; Miller FN
    Am J Physiol; 1982 Dec; 243(6):H844-51. PubMed ID: 6756169
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the behavioral and hypotensive effects of intraventricular prostacyclin (PGI2) in rats.
    Brus K; Szkilnik R; Słomińska-Zurek J; Krzemiński T; Herman ZS
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):467-74. PubMed ID: 7036117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of prostacyclin on intestinal ion transport in the rat.
    Hardcastle J; Hardcastle PT; Redfern JS
    Life Sci; 1980 Jan; 26(2):123-31. PubMed ID: 6245315
    [No Abstract]   [Full Text] [Related]  

  • 35. 11- and 15-deoxy-carboprostacyclins: hypothetic prostacyclin antagonists.
    Mongelli N; Magni O; Gandolfi C; Grossoni M; Ceserani R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():281-5. PubMed ID: 6221538
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of prostaglandins on gastric acid and mucus secretion.
    Metsä-Ketelä T; Parantainen J; Vapaatalo H
    Adv Prostaglandin Thromboxane Res; 1980; 8():1553-6. PubMed ID: 6990727
    [No Abstract]   [Full Text] [Related]  

  • 37. Central cardiovascular and thermal effects of prostacyclin in rats.
    Sirén A
    Prostaglandins; 1981 Dec; 22(6):945-56. PubMed ID: 7038775
    [No Abstract]   [Full Text] [Related]  

  • 38. Differences in blood pressure lowering effects in PGs following indirect and direct blood pressure measurements.
    Hedley LR; Van Antwerp DR; Strosberg AM
    Proc West Pharmacol Soc; 1984; 27():323-7. PubMed ID: 6593737
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardiocirculatory effects of prostacyclin in humans].
    Triulzi MO; Cirino D; Balice G; Gentile F; Maggi GC
    Boll Soc Ital Cardiol; 1981; 26(12):2043-9. PubMed ID: 6764359
    [No Abstract]   [Full Text] [Related]  

  • 40. The general pharmacology of prostacyclin (pgi2, pgx): a new prostaglandin especially activity on the cardiovascular system.
    Weeks JR
    Pol J Pharmacol Pharm; 1978; 30(2-3):215-21. PubMed ID: 97642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.